Mutual Funds Increase Holdings Across All Market Caps in July 2026

Mutual funds significantly expanded their equity exposure across large-, mid-, and small-cap segments in July 2026, reflecting a broad-based positive sentiment among fund managers. This strategic buying activity, detailed by Value Research, spanned diverse sectors.

The investment trend encompassed pharmaceuticals, banking, technology, healthcare, alongside financial and consumer services. Fund managers showed interest in both the stability offered by large-caps and the growth potential, albeit with increased risk, of mid- and small-cap stocks.

Key Large-Cap Additions

• Torrent Pharmaceuticals led large-cap purchases with ₹7,014 crore.
• Adani Enterprises followed, attracting ₹6,743 crore in investments.
• Axis Bank saw additions of ₹3,522 crore.
• Kotak Mahindra Bank recorded buys worth ₹3,262 crore.
• SBI Funds Management garnered ₹2,344 crore.
• Union Bank of India also received investments totaling ₹1,002 crore.

Mid-Cap Focus: Biocon Leads

• Biocon emerged as the top mid-cap pick, with funds purchasing shares valued at ₹3,234 crore.
• PB Fintech attracted substantial investment, reaching ₹2,875 crore.
• Lenskart Solutions and Swiggy each recorded purchases exceeding ₹1,000 crore.
• Meesho also saw significant buying activity, totaling ₹860 crore.

Small-Cap Outperformers

• Diamond Power Infrastructure headed the small-cap segment with ₹1,605 crore in purchases.
• Jupiter Life Line Hospitals garnered investments of ₹1,126 crore.
• Sterlite Technologies also featured prominently, with ₹1,108 crore in buying.

This widespread investment across market capitalizations underscores the strategic decisions by mutual fund managers. Their diversified approach in July 2026 suggests a confident outlook across various growth and stability profiles within the Indian equity market.